← All Chemed CORP filings

Chemed CORP Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NYSE
CHE
Chemed CORP
Form 4: Chemed CEO Receives Stock Grant
Joel L Wherley, CEO - Vitas Healthcare of Chemed Corp, received 12,686 shares of common stock on October 20, 2026.
NYSE
CHE
Chemed CORP
Form 4: Chemed President Receives Stock Grant
Spencer S Lee, executive vice president of Chemed Corp, received 7,125 shares of common stock on October 20, 2026.
NYSE
CHE
Chemed CORP
Form 4: Chemed Executive Receives Stock Grant
Brian C Judkins, VP and Chief Legal Officer of Chemed Corp, received 9,392 shares of common stock on October 20, 2026.
NYSE
CHE
Chemed CORP
Form 4: Chemed President Receives Stock Grant
Thomas C Hutton, vice president and a Director of Chemed Corp, received 3,964 shares of common stock on October 20, 2026.
NYSE
CHE
Chemed CORP
Form 4: Chemed CFO Receives Stock Grant
Michael D Witzeman, VP & Chief Financial Officer of Chemed Corp, received 12,686 shares of common stock on October 20, 2026.
NYSE
CHE
Chemed CORP
Form 4: Chemed CEO Receives Stock Grant
Kevin J Mcnamara, president and CEO and a Director of Chemed Corp, received 36,693 shares of common stock on October 20, 2026.
NYSE
CHE
Chemed CORP
Form 4: Chemed President Reports Stock Transaction
Spencer S Lee, executive vice president of Chemed Corp, reported multiple transactions in common stock on September 30, 2026.
NYSE
CHE
Chemed CORP
Form 4: Chemed CEO Sells Shares
Kevin J Mcnamara, president and CEO and a Director of Chemed Corp, sold 2,000 shares of common stock on September 28, 2026 for $513.45 per share.
NYSE
CHE
Chemed CORP
Form 4: Chemed President Reports Stock Transaction
Thomas C Hutton, vice president and a Director of Chemed Corp, reported multiple transactions in common stock on September 28, 2026.
NYSE
CHE
Chemed CORP
Form 4: Chemed CEO Sells Shares
Kevin J Mcnamara, president and CEO and a Director of Chemed Corp, sold 2,000 shares of common stock on September 18, 2026 for $501.40 per share.
NYSE
CHE
Chemed CORP
Form 4: Chemed President Sells Shares
Spencer S Lee, executive vice president of Chemed Corp, sold 1,000 shares of common stock on August 21, 2026 for $541.04 per share.
NYSE
CHE
Chemed CORP
Form 4: Chemed CEO Sells Shares
Kevin J Mcnamara, president and CEO and a Director of Chemed Corp, sold 2,000 shares of common stock on August 21, 2026 for $541.16 per share.
NYSE
CHE
Chemed CORP
Form 4: Chemed Executive Reports Stock Transaction
Brian C Judkins, VP and Chief Legal Officer of Chemed Corp, reported multiple transactions in common stock on August 10, 2026.
NYSE
CHE
Chemed CORP
Form 4: Chemed CEO Reports Stock Transaction
Joel L Wherley, CEO - Vitas Healthcare of Chemed Corp, reported multiple transactions in common stock on August 5, 2026.
NYSE
CHE
Chemed CORP
Form 4: Chemed CEO Sells Shares
Kevin J Mcnamara, president and CEO and a Director of Chemed Corp, sold 2,000 shares of common stock on July 31, 2026 for $539.51 per share.
NYSE
CHE
Chemed CORP
Form 4: Chemed Director Sells Shares
Patrick P Grace, a Director of Chemed Corp, sold 190 shares of common stock on July 31, 2026 for $532.00 per share.
NYSE
CHE
Chemed CORP
Form 4: Chemed Corp Director Acquires Shares
Chemed Corp Director Andrea R. Lindell reported the acquisition of 1,347 shares of capital stock.
NYSE
CHE
Chemed CORP
Form 4: Director George J. Walsh III Sells Chemed Corp Shares
Director George J. Walsh III sold 500 shares of Chemed Corp common stock at a price of $437.83 per share.
NYSE
CHE
Chemed CORP
Form 4: Chemed Corp Director Walsh Acquires Shares
Chemed Corp director George J. Walsh III acquired 386 shares of company stock on May 18, 2026, valued at $440.77 per share.
NYSE
CHE
Chemed CORP
Form 4: Chemed Corp Director Acquires Shares
Chemed Corp Director John Meredith Mount Jr. acquired 386 shares of capital stock.
NYSE
CHE
Chemed CORP
Form 4: Eileen McCarthy Reports CHEMED CORP Stock Acquisition
Eileen P. McCarthy, a Director at CHEMED CORP, reported the acquisition of 386 shares of Capital Stock on May 18, 2026.
NYSE
CHE
Chemed CORP
Form 4: Chemed Corp Director Acquires Shares
Chemed Corp Director Andrea R. Lindell acquired 386 shares of capital stock on May 18, 2026, increasing her direct beneficial ownership.
NYSE
CHE
Chemed CORP
Form 4: Chemed Corp Director Acquires Shares
Chemed Corp director Christopher J. Heaney acquired 386 shares of company stock on May 18, 2026, valued at $440.77 per share.
NYSE
CHE
Chemed CORP
Form 4: Grace Acquires Chemed Corp Stock
Patrick P. Grace, a Director at Chemed Corp, reported the acquisition of 386 shares of company stock on May 18, 2026.
NYSE
CHE
Chemed CORP
Form 4: Chemed Corp Director Acquires Shares
Ron DeLyons, a Director at Chemed Corp, reported the acquisition of 386 shares of company stock on May 18, 2026.
NYSE
CHE
Chemed CORP
Form 4: Director Patrick P. Grace Sells Chemed Corp Shares
Director Patrick P. Grace sold 60 shares of Chemed Corp common stock at a price of $425.78 per share.
NYSE
CHE
Chemed CORP
Form 4: Chemed Corp Insider Sells Shares
Kevin J. McNamara, President and CEO of Chemed Corp, reported a sale of 2,000 shares of capital stock on May 1, 2026.
NYSE
CHE
Chemed CORP
Form 4: Chemed CEO McNamara sells 1,500 shares
Chemed Corp CEO and director Kevin J. McNamara sold 1,500 shares at a $369.37 weighted average on March 27, 2026, and now holds 92,219 shares directly.
NYSE
CHE
Chemed CORP
Form 4: CHEMED CEO Sells 2,000 Shares
CHEMED Corp's President and CEO, Kevin J. McNamara, sold 2,000 shares of company stock for a weighted average price of $403.18 per share.
NYSE
CHE
Chemed CORP
Form 4: CHEMED VP Acquires Shares, New PSUs After Performance Vesting
CHEMED Corp's VP and Chief Legal Officer, Brian C. Judkins, acquired shares from vested performance stock units and received a new grant of PSUs, while also having shares withheld for taxes.